Global HPV Vaccine Market: Analysis By End-User (Male, Female), By Age Group (Adolescents, Adults) - By Region, By Country (2017-2022)
• By Region- North America, Europe,
APAC and RoW • By Country - United States, Canada, United Kingdom, Germany, France, China, India, Japan
• Company Analysis
(c) AZOTH Analytics
March 2018
Table of Content S.No
Particulars
Page No.
1.
Research Methodology
19
2.
Executive Summary
20
3.
Strategic Recommendation
21
3.1
Asia Pacific Region to witness fastest growth for HPV Treatment
22
3.2
Male segment is anticipated to witness highest growth
23
4.
HPV Vaccine Market: Product Outlook
24
5.
Global HPV Vaccine Market: Growth and Forecast
31
5.1
Global HPV Vaccine Market, By Value (2012-2016)
32
5.2
Global HPV Vaccine Market, By Value (2017-2022)
40
5.3
Global HPV Vaccine Market - By End-User, By Value
41
5.3.1
Global HPV Vaccine Market, By Value, % (2016)
41
5.3.2
Global HPV Vaccine Market, By Value, % (Forecast 2022F)
42
(c) AZOTH Analytics
2
Table of Content S.No
Particulars
5.4
5.5
6.
Page No.
Global HPV Vaccine Market, By End-User, By Value (2012-2022)
43
5.4.1
Male, By Value (2012-2022)
43
5.4.2
Female, By Value (2012-2022)
43
Global HPV Vaccine Market, By Age-Group, By Value (2012-2022)
44
5.5.1
Adolescent, By Value (2012-2022)
44
5.5.2
Adult, By Value (2012-2022)
44
North America HPV Vaccine Market: Growth and Forecast
46
6.1
North America HPV Vaccine Market, By Value (2012-2016)
47
6.2
North America HPV Vaccine Market, By Value (2017-2022)
50
6.3
North America HPV Vaccine Market - By End-User, By Value
51
6.3.1
North America HPV Vaccine Market, By Value, % (2016)
51
6.3.2
North America HPV Vaccine Market, By Value, % (Forecast 2022F)
52
6.4
North America HPV Vaccine Market, By End-User, By Value (2012-2022)
53
6.4.1
Male, By Value (2012-2022)
53
6.4.2
Female, By Value (2012-2022)
53
(c) AZOTH Analytics
3
Table of Content S. No
Particulars
6.5
6.6
6.7
6.8
6.9
6.10
North America HPV Vaccine Market, By Age-Group, By Value (2012-2022)
Page No.
54
6.5.1
Adolescent, By Value (2012-2022)
54
6.5.2
Adult, By Value (2012-2022)
54
North America HPV Vaccine Market: Country Analysis (U.S., Canada)
55
6.6.1
North America HPV Vaccine Market, Country Share, 2016 (% of Total)
55
6.6.2
North America HPV Vaccine Market, Country Share, 2022 (% of Total)
55
U.S. HPV Vaccine Market: Growth and Forecast
57
6.7.1
U.S. HPV Vaccine Market, By Value (2012-2016)
58
6.7.2
U.S. HPV Vaccine Market, By Value (2017-2022)
58
U.S. HPV Vaccine Market - By End-User, By Value
64
6.8.1
Male, By Value (2012-2022)
64
6.8.2
Female, By Value (2012-2022)
64
Canada HPV Vaccine Market: Growth and Forecast
66
6.9.1
Canada HPV Vaccine Market, By Value (2012-2016)
67
6.9.2
Canada HPV Vaccine Market, By Value (2017-2022)
67
Canada HPV Vaccine Market - By End-User, By Value
74
6.10.1
Male, By Value (2012-2022)
74
6.10.2
Female, By Value (2012-2022)
74
(c) AZOTH Analytics
4
Table of Content S.No
7.
Particulars
Europe HPV Vaccine Market: Growth and Forecast
Page No.
75
7.1
Europe HPV Vaccine Market, By Value (2012-2016)
76
7.2
Europe HPV Vaccine Market, By Value (2017-2022)
80
7.3
Europe HPV Vaccine Market - By End-User, By Value
81
7.3.1
Europe HPV Vaccine Market, By Value, % (2016)
81
7.3.2
Europe HPV Vaccine Market, By Value, % (Forecast 2022F)
82
7.4
7.5
7.6
Europe HPV Vaccine Market, By End-User, By Value (2012-2022)
83
7.4.1
Male, By Value (2012-2022)
83
7.4.2
Female, By Value (2012-2022)
83
Europe HPV Vaccine Market, By Age-Group, By Value (2012-2022)
84
7.5.1
Adolescent, By Value (2012-2022)
84
7.5.2
Adult, By Value (2012-2022)
84
Europe HPV Vaccine Market: Country Analysis (U.K., Germany, France & Rest of Europe)
85
7.6.1
Europe HPV Vaccine Market, Country Share, 2016 (% of Total)
85
7.6.2
Europe HPV Vaccine Market, Country Share, 2022 (% of Total)
85
(c) AZOTH Analytics
5
Table of Content S. No
Particulars
7.7
7.8
7.9
7.10
U.K. HPV Vaccine Market: Growth and Forecast
Page No.
88
7.7.1
U.K. HPV Vaccine Market, By Value (2012-2016)
89
7.7.2
U.K. HPV Vaccine Market, By Value (2017-2022)
89
U.K. HPV Vaccine Market - By End-User, By Value
94
7.8.1
Male, By Value (2012-2022)
94
7.8.2
Female, By Value (2012-2022)
94
Germany HPV Vaccine Market: Growth and Forecast
96
7.9.1
Germany HPV Vaccine Market, By Value (2012-2016)
97
7.9.2
Germany HPV Vaccine Market, By Value (2017-2022)
97
Germany HPV Vaccine Market - By End-User, By Value
104
7.10.1
Male, By Value (2012-2022)
104
7.10.2
Female, By Value (2012-2022)
104
(c) AZOTH Analytics
6
Table of Content S. No
Particulars
7.11
7.12
7.13
8.
Page No.
France HPV Vaccine Market: Growth and Forecast
105
7.11.1
France HPV Vaccine Market, By Value (2012-2016)
105
7.11.2
France HPV Vaccine Market, By Value (2017-2022)
106
France HPV Vaccine Market - By End-User, By Value
111
7.12.1
Male, By Value (2012-2022)
111
7.12.2
Female, By Value (2012-2022)
111
Rest of Europe HPV Vaccine Market: Growth and Forecast
112
7.13.1
Rest of Europe HPV Vaccine Market, By Value (2012-2016)
112
7.13.2
Rest of Europe Vaccine Market, By Value (2017-2022)
112
Asia-Pacific HPV Vaccine Market: Growth and Forecast
113
8.1
Asia-Pacific HPV Vaccine Market, By Value (2012-2016)
114
8.2
Asia-Pacific HPV Vaccine Market, By Value (2017-2022)
120
8.3
Asia-Pacific HPV Vaccine Market - By End-User, By Value
121
8.3.1
Asia-Pacific HPV Vaccine Market, By Value, % (2016)
121
8.3.2
Asia-Pacific HPV Vaccine Market, By Value, % (Forecast 2022F)
122
(c) AZOTH Analytics
7
Table of Content S.No
Particulars
8.4
8.5
8.6
8.7
8.8
Page No.
Asia-Pacific HPV Vaccine Market, By End-User, By Value (2012-2022)
123
8.4.1
Male, By Value (2012-2022)
123
8.4.2
Female, By Value (2012-2022)
123
Asia-Pacific HPV Vaccine Market, By Age-Group, By Value (2012-2022)
124
8.5.1
Adolescent, By Value (2012-2022)
124
8.5.2
Adult, By Value (2012-2022)
124
Asia-Pacific HPV Vaccine Market: Country Analysis (Japan, China, India)
125
8.6.1
Asia-Pacific HPV Vaccine Market, Country Share, 2016 (% of Total)
125
8.6.2
Asia-Pacific HPV Vaccine Market, Country Share, 2022 (% of Total)
125
Japan HPV Vaccine Market: Growth and Forecast
127
8.7.1
Japan HPV Vaccine Market, By Value (2012-2016)
128
8.7.2
Japan HPV Vaccine Market, By Value (2017-2022)
128
Japan HPV Vaccine Market - By End-User, By Value 8.8.1
Male, By Value (2012-2022)
8.8.2
Female, By Value (2012-2022)
131 11
131
(c) AZOTH Analytics
8
Table of Content S. No
Particulars
8.9
8.10
8.11
8.12
9.
China HPV Vaccine Market: Growth and Forecast
Page No.
132
8.9.1
China HPV Vaccine Market, By Value (2012-2016)
133
8.9.2
China HPV Vaccine Market, By Value (2017-2022)
133
China HPV Vaccine Market - By End-User, By Value
139
8.10.1
Male, By Value (2012-2022)
139
8.10.2
Female, By Value (2012-2022)
139
India HPV Vaccine Market: Growth and Forecast
140
8.11.1
India HPV Vaccine Market, By Value (2012-2016)
141
8.11.2
India HPV Vaccine Market, By Value (2017-2022)
141
India HPV Vaccine Market - By End-User, By Value
147
8.12.1
Male, By Value (2012-2022)
147
8.12.2
Female, By Value (2012-2022)
147
ROW HPV Vaccine Market: Growth and Forecast
148
9.1
ROW HPV Vaccine Market, By Value (2012-2016)
149
9.2
ROW HPV Vaccine Market, By Value (2017-2022)
150
(c) AZOTH Analytics
9
Table of Content S. No
10.
Particulars
Market Dynamics
Page No.
153
10.1
Increasing healthcare awareness about Sexually Transmissible Disease
155
10.2
Development of Healthcare Infrastructure
156
10.3
Rising global healthcare expenditure and favorable reimbursed policies
157
11.
Market Restraints
158
12.
Market Trends
160
13.
SWOT Analysis – HPV Vaccine Market
163
14.
Porter’s Five Forces Analysis
165
15.
Policy and Regulatory Landscape
167
16.
Company Profile
177
17.
16.1
Merck and Co
16.2
GlaxoSmithKline
178 181
About Us
184
(c) AZOTH Analytics
10
List of Figures Figure No.
Figure Title
Page No.
Figure 1:
Global HPV vaccine Market Size, By Value, 2012-2016 (USD Million)
32
Figure 2:
World Male Population Estimates, 2017 (In Millions)
33
Figure 3:
World Female Population Estimates, 2017 (In Millions)
33
Figure 4:
World Female Population, Age 10-14 Years Old (2012-2016)
34
Figure 5:
World Male Population, Age 10-14 Years Old (2012-2016)
34
Figure 6:
Global Healthcare Expenditure, 2012-2016 (In Trillion)
36
Figure 7:
Top 10 Most Frequent Cancer in Females, World, (Age−standardised incidence rate per 100,000 women)
37
Figure 8:
Top 10 Most Frequent Cancer Deaths in Females, World, (Age−standardised incidence rate per 100,000 women)
37
Figure 9:
Age-Standardized Cervical Cancer Incidence Rate (per 100,000 women per year), By Region
37
Figure 10:
HPV Related Cancer Cases in Women/ Year, 530,000
38
Figure 11:
HPV Related Cancer Cases in Men/ Year, 39,000
38
Figure 12:
Global HPV Vaccine Market Size, By Value, 2017-2022 (USD Million)
40
Figure 13:
Global HPV vaccine Market Size, By End-User, 2016 (%)
41
Figure 14:
Global HPV Vaccine Market Size, By End-User, 2022 (%)
42
Figure 15:
Global HPV Vaccine Market - End-User, By Value 2012-2022 (USD Million)
43
Figure 16:
Global HPV Vaccine Market – By Age Group, By Value 2012-2022 (USD Million)
44
Figure 17:
North America HPV Vaccine Market Size, By Value, 2012-2016 (USD Million)
47
Figure 18:
North America GDP, 2012-2015 (USD Trillion)
48
Figure 19:
North America GDP, By Select Country, 2016 (USD Trillion)
48
(c) AZOTH Analytics
11
List of Figures Figure No.
Figure Title
Page No.
Figure 20:
North America Healthcare Cost Per Capita, By Select Country, 2016 (USD)
48
Figure 21:
North America Female Population, Age 10-14 Years Old (2012-2016)
49
Figure 22:
North America Male Population, Age 10-14 Years Old (2012-2016)
49
Figure 23:
North America HPV Vaccine Market Size, By Value, 2017-2022(USD Million)
50
Figure 24:
North America HPV vaccine Market Size, By End-User , 2016 (%)
51
Figure 25:
North America HPV Vaccine Market Size, By End-User, 2022 (%)
52
Figure 26:
North America HPV Vaccine Market, End-User, By Value 2012-2022 (USD Million)
53
Figure 27:
North America HPV Vaccine Market, By Age Group, By Value 2012-2022 (USD Million)
54
Figure 28:
North America HPV Vaccine Market, Country Share, 2016 (% of Total)
55
Figure 29:
North America HPV Vaccine Market, Country Share, 2022 (% of Total)
55
Figure 30:
U.S. HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)
58
Figure 31:
U.S. Female Population, Age 10-14 Years Old (2012-2016)
61
Figure 32:
U.S. Male Population, Age 10-14 Years Old (2012-2016)
61
Figure 33:
U.S. Per Capita Healthcare Expenditure, 2012-2016 (In USD)
61
Figure 34:
U.S. HPV vaccine Market Size, By End-User, 2016 (%)
62
Figure 35:
U.S. HPV Vaccine Market Size, By End-User, 2022 (%)
63
Figure 36:
U.S. HPV Vaccine Market - End-User, By Value 2012-2022 (USD Million)
64
Figure 37:
Annual Sales of Cervarix vaccines in U.S., (In Million USD) 2012-2016
65
Figure 38:
Canada HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)
67
Figure 39:
Canada Female Population, Age 10-14 Years Old (2012-2016)
68
(c) AZOTH Analytics
12
List of Figures Figure No.
Figure Title
Page No.
Figure 40:
Canada Male Population, Age 10-14 Years Old (2012-2016)
68
Figure 41:
Normal Cytology
70
Figure 42:
Low-Grade lesions
70
Figure 43:
High-Grade lesions
70
Figure 44:
Cervical Cancer
70
Figure 45:
Prevalence of Cervical Cancer among female (Patients per 100,000) (2012-2016)
71
Figure 46:
Canada HPV vaccine Market Size, By End-User, 2016 (%)
72
Figure 47:
Canada HPV Vaccine Market Size, By End-User, 2022 (%)
73
Figure 48:
Canada HPV Vaccine Market - By End-User, By Value 2012-2022 (USD Million)
74
Figure 49:
Europe HPV Vaccine Market Size, By Value, 2012-2016 (USD Million)
76
Figure 50:
Europe, Female Population aged 15+, By Region, 2017 (In Millions)
77
Figure 51:
European Union, Per Capita Healthcare Expenditure, 2012-2014 (In USD)
77
Figure 52:
Europe Female Population, Age 10-14 Years Old (2012-2016)
77
Figure 53:
Europe Male Population, Age 10-14 Years Old (2012-2016)
77
Figure 54:
Europe, GDP, By Select Country, 2016 (USD Billion)
78
Figure 55:
Europe Health Spending Per Capita, By Select Country, 2016 (USD)
78
Figure 56:
Europe HPV Vaccine Market Size, By Value, Forecast, 2017-2022 (USD Million)
80
Figure 57:
Europe HPV Vaccine Market Size, By End-User, 2016 (%)
81
Figure 58:
Europe HPV Vaccine Market Size, By End-User, 2022 (%)
82
Figure 59:
Europe HPV Vaccine Market - End-User, By Value 2012-2022 (USD Million)
83
Figure 60:
Europe HPV Vaccine Market – By Age Group, By Value 2012-2022 (USD Million)
84
(c) AZOTH Analytics
13
List of Figures Figure No.
Figure Title
Page No.
Figure 61:
Europe HPV Vaccine Market, Country Share, 2016 (% of Total)
85
Figure 62:
Europe HPV Vaccine Market, Country Share, 2022 (% of Total)
85
Figure 63:
Annual Sales of Cervarix vaccines in Europe, (In Million USD) 2012-2016
86
Figure 64:
U.K. HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)
89
Figure 65:
U.K. Female Population, Age 10-14 Years Old (2012-2016)
91
Figure 66:
U.K. Male Population, Age 10-14 Years Old (2012-2016)
91
Figure 67:
Prevalence of Cervical Cancer among female (Patients per 100,000) (2012-2016)
91
Figure 68:
U.K., Per Capita Healthcare Expenditure, 2012-2016 (In USD)
91
Figure 69:
U.K. HPV Vaccine Market Size, By End User, 2016 (%)
92
Figure 70:
U.K. HPV Vaccine Market Size, By End User, 2022 (%)
93
Figure 71:
U.K. HPV Vaccine Market - End-User, By Value 2012-2022 (USD Million)
94
Figure 72:
Germany HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)
97
Figure 73:
Germany Female Population, Age 10-14 Years Old (2012-2016)
98
Figure 74:
Germany Male Population, Age 10-14 Years Old (2012-2016)
98
Figure 75:
Germany Per Capita Healthcare Expenditure, 2012 - 2014 (In USD)
98
Figure 76:
Prevalence of Cervical Cancer among female (Patients per 100,000) (2012-2016)
99
Figure 77:
Germany HPV Vaccine Market Size, By End User, 2016 (%)
102
Figure 78:
Germany HPV Vaccine Market Size, By End User, 2022 (%)
103
Figure 79:
Germany HPV Vaccine Market - By End-User, By Value 2012-2022 (USD Million)
104
Figure 80:
France HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)
106
(c) AZOTH Analytics
14
List of Figures Figure No.
Figure Title
Page No.
Figure 81:
Prevalence of Cervical Cancer among female (Patients per 100,000) (2012-2016)
107
Figure 82:
France Female Population, Age 10-14 Years Old (2012-2016)
108
Figure 83:
France Male Population, Age 10-14 Years Old (2012-2016)
108
Figure 84:
France Per Capita Healthcare Expenditure, 2012-2014 (In USD)
108
Figure 85:
France HPV Vaccine Market Size, By End-User, 2016 (%)
109
Figure 86:
France HPV Vaccine Market Size, By End-User, 2022 (%)
110
Figure 87:
France HPV Vaccine Market - By End-User, By Value 2012-2022 (USD Million)
111
Figure 88:
Rest of Europe HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)
112
Figure 89:
Asia-Pacific HPV Vaccine Market Size, By Value, 2012-2016 (USD Million)
114
Figure 90:
Asia Female Population, Age 10-14 Years Old (2012-2016)
118
Figure 91:
Asia Male Population, Age 10-14 Years Old (2012-2016)
118
Figure 92:
APAC, GDP, By Select Country, 2016 (USD Billion)
119
Figure 93:
APAC Health Expenditure Per Capita, Public and Private, By Select Country, 2016 (USD)
119
Figure 94:
Asia-Pacific HPV Vaccine Market Size, By Value, 2017-2022 (USD Million)
120
Figure 95:
Asia-Pacific HPV Vaccine Market Size, By End-User, 2016 (%)
121
Figure 96:
Asia-Pacific HPV Vaccine Market Size, By End-User, 2022 (%)
122
Figure 97:
Asia-pacific HPV Vaccine - End-User, By Value 2012-2022 (USD Million)
123
Figure 98:
Asia-Pacific HPV Vaccine Market – Age Group, By Value 2012-2022 (USD Million)
124
Figure 99:
Asia-Pacific HPV Vaccine Market, Country Share, 2016 (% of Total)
125
Figure 100:
Asia-Pacific HPV Vaccine Market, Country Share, 2022 (% of Total)
125
(c) AZOTH Analytics
15
List of Figures Figure No.
Figure Title
Page No.
Figure 101:
Japan HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)
128
Figure 102:
Japan HPV Vaccine Market Size, By End-User, 2016 (%)
129
Figure 103:
Japan HPV Vaccine Market Size, By End-User, 2022 (%)
130
Figure 104:
Japan HPV Vaccine - End-User, By Value 2012-2022 (USD Million)
131
Figure 105:
China HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)
133
Figure 106:
Prevalence of Cervical Cancer among female (Patients per 100,000) (2012-2016)
135
Figure 107:
China Female Population, Age 10-14 Years Old (2012-2016)
136
Figure 108:
China Male Population, Age 10-14 Years Old (2012-2016)
136
Figure 109:
China Per Capita Healthcare Expenditure, 2012-2014 (In USD)
136
Figure 110:
China HPV Vaccine Market Size, By End-User, 2016 (%)
137
Figure 111:
China HPV Vaccine Market Size, By End-User, 2022 (%)
138
Figure 112:
China HPV Vaccine - By End-User, By Value 2012-2022 (USD Million)
139
Figure 113:
India HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)
141
Figure 114:
India Female Population, Age 10-14 Years Old (2012-2016)
143
Figure 115:
India Male Population, Age 10-14 Years Old (2012-2016)
143
Figure 116:
Prevalence of Cervical Cancer among female (Patients per 100,000) (2012-2016)
143
Figure 117:
India HPV Vaccine Market Size, By End-User, 2016 (%)
144
Figure 118:
India HPV Vaccine Market Size, By End-User, 2022 (%)
145
Figure 119:
India HPV Vaccine - By End-User, By Value 2012-2022 (USD Million)
146
Figure 120:
Rest of Asia-Pacific HPV Vaccine Market Size, By Value, 2012-2022 (USD Million)
147
(c) AZOTH Analytics
16
List of Figures Figure No.
Figure Title
Page No.
Figure 121:
ROW HPV Vaccine Market Size, By Value, 2012-2016 (USD Million)
149
Figure 122:
ROW HPV Vaccine Market Size, By Value, 2017-2022 (USD Million)
150
Figure 123:
Africa Female Population, Age 10-14 Years Old (2012-2016)
151
Figure 124:
Africa Male Population, Age 10-14 Years Old (2012-2016)
151
Figure 125:
Prevalence of Cervical Cancer, among women in Africa (Patients per 100,000 (2012-2016)
151
Figure 126:
Prevalence of Cervical Cancer among female in Brazil (Patients per 100,000 (2012-2016)
152
Figure 127:
Global Healthcare Expenditure, 2012-2016 (In Trillion)
157
Figure 128:
Annual Sales of HPV vaccines, By leading players, (In Million USD) 2012-2016
175
Figure 129:
Market Share of Leading players in HPV vaccine market, 2016
176
Figure 130:
Merck & Co., Net Sales, 2012-2016 (In million USD)
179
Figure 131:
Merck & Co, Net Sales of Gardasil/Gardasil 9, 2012-2016 (In million USD)
179
Figure 132:
Merck & Co., Net Sales, By Geographic Location, % Share 2016
179
Figure 133:
Merck & Co., Net Revenue, By Business Segment, % Share 2016
179
Figure 134:
GlaxoSmithKline Annual Revenue, 2014-2016 (USD Million)
182
Figure 135:
Sales from Hepatitis Vaccination, GlaxoSmithKline, 2015 - 2016 (USD Million)
182
Figure 136:
GlaxoSmithKline Sales, By Region, 2016 (%)
182
Figure 137:
GlaxoSmithKline, Sales, By Segment 2016 (%)
182
(c) AZOTH Analytics
17
List of Tables Table No.
Table A:
Table B:
Table C:
Table D:
Table E:
Table F:
Table G:
Table H:
Table I:
Table Title
Globally approved HPV vaccines, 2016
Page No.
29
HPV Vaccine Market Segmentation Flowchart
30
Estimated number of HPV Associated cases in 2017
Estimated new HPV related cancers cases, 2011, 2012 & 2016 Newly registered diagnosed cases of HPV related cancer in England, 2016
Estimated and Predicted HPV related cancer among male and female, 2011, 2012 & 2016
Estimated and Predicted HPV related cancer among female, 2011, 2012 & 2016
Key Statistics on HPV burden in Asia
59
69
90
100
100
114
Estimated HPV related New Cancer Cases and Deaths (Thousands), By Sex, 2015
(c) AZOTH Analytics
135
18
Research Methodology For our study on Global HPV Vaccine Market, we have conducted comprehensive secondary research followed by an extensive primary research. In the process of secondary research, we have scrutinized industry documents, accessed from open sources, premium paid databases (Bloomberg, Thomson Reuters, Factiva) and our internal knowledge base. In the process of primary research, we have interviewed various industry experts across the value chain of HPV Vaccine Market. Market size of the actual period (2012-2016) has been evaluated on the basis of growth trends of the industry in the last five years, and confirming the findings through primary research. Annual reports of the companies are scanned to further validate the market size and to estimate the size of various other end-user sectors.
Market sizing and growth in the forecast period (2017-2022) is estimated through product mapping, application in end-user industries, growth of allied sectors and historical growth pattern of the industry. All the relevant data points/ statistics in the forecast period are validated through relevant and reliable primary sources.
Report Focus: HPV Vaccine Market -By Region- North America, Europe, APAC and ROW -By Country - United States, Canada, United Kingdom, Germany, France, China, India, Japan Company Analysis
Companies Contacted: GlaxoSmithKline Pharmaceuticals Ltd
(c) AZOTH Analytics
19
Global HPV Vaccine Market Overview Rising Prevalence of Sexually Transmissible Diseases, increasing global adolescence population, growing healthcare burden due to Sexually Transmissible virus propelled the market growth Figure : Global HPV vaccine Market Size, By Value, 2012-2016 (USD Million) CAGR 2012-2016 HPV: xx%;
2012
2013
2014 Source: Azoth Analytics Estimates
2015
2016
Xxxxx
Xxxxx Xxxxx Xxxxx Xxxxx xxxxx
(c) AZOTH Analytics
20
Global HPV Vaccine Market - By Age Group, By Value Figure : Global HPV Vaccine Market – By Age Group, By Value 2012-2022 (USD Million)
2012
CAGR 2012-2016
CAGR 2017-2022
Adolescent: xx%; Adult: xx%
Adolescent: xx%; Adult: xx%
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Source: Azoth Analytics Estimates Xxxxx Xxxxx Xxxxx
Xxxxx Xxxxx xxxxx
(c) AZOTH Analytics
21
North America HPV Vaccine Market - By End-User, By Value Higher healthcare burden due to Cervical Cancer caused by HPV virus is attributed to the larger market share in female segment
Figure : North America HPV vaccine Market Size, By
Key Drivers
End-User , 2016 (%)
Xxxxx xxxxx Male
Xxxxx xxxxx
Xxxxx Female
xxxxx
Xxxxx xxxxx Source: Azoth Analytics Estimates
(c) AZOTH Analytics
22
Germany HPV Vaccine Market - By End-User, By Value Figure : Germany HPV Vaccine Market - By End-User, By Value 2012-2022 (USD Million)
2012
CAGR 2012-2016
CAGR 2017-2022
Male: xx%; Female: xx%
Male: xx%; Female: xx%
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Source: Azoth Analytics Estimates Xxxxx Xxxxx Xxxxx Xxxxx xxxxx
(c) AZOTH Analytics
23
Asia-Pacific HPV Vaccine Market - By Country Share
Figure : Asia-Pacific HPV Vaccine Market, Country
Figure : Asia-Pacific HPV Vaccine Market, Country
Share, 2016 (% of Total)
Share, 2022 (% of Total)
Source: Azoth Analytics Estimates
Japan
Japan
China
China
India
India
Others
Others
Source: Azoth Analytics Estimates
(c) AZOTH Analytics
24
About Azoth Analytics Pvt Ltd. Azoth Analytics is a business research and analytics firm that creates in-depth research res and provides customized research solutions and consultancy services. Verticals in which Azoth Analytics specializes include healthcare and Pharmaceutical, oil and gas, retail, chemicals, automotive, FMCG, food & beverages and technology. Azoth creates comprehensive and in-depth research res by recording, interpreting and analyzing information. Strategic market sizing and data dredging End Users include secondary research, and primary research (interviews with management personnel and industry experts).
Disclaimer: Azoth Analytics report information is based mainly on interviews and therefore, is subject to fluctuation. Azoth Analytics therefore, takes no responsibility for any incorrect information supplied to us by industry experts, manufacturers or User.. Also, analysis provided in the re are meant for customers’ internal use only and not for general publication or disclosure to third parties.
(c) AZOTH Analytics
25